SacredBod's longer take on Thyme Leaf — context the structured blocks above don't capture.
Thymus vulgaris is a Mediterranean herb rich in thymol and carvacrol, phenolic compounds with well-documented antimicrobial, antispasmodic, and expectorant properties. Thyme extract (especially the proprietary formulation Bronchipret® Saft) has been evaluated in RCTs for acute bronchitis in children and adults, showing modest but significant benefits over placebo.
Thymol disrupts bacterial cell membranes and inhibits biofilm formation. It also has mild antispasmodic effects on bronchial smooth muscle and stimulates ciliary beat frequency, potentially enhancing mucus clearance. Carvacrol contributes additional antimicrobial activity. These effects are documented in vitro and in animal models; human respiratory data is more limited.
Who benefits most
Adults with acute bronchitis or respiratory infection seeking herbal adjunctive support. Not a substitute for antibiotics when bacterial infection is confirmed, or for medical evaluation of severe dyspnea or hemoptysis.
Dosage and form
500 mg is the typical effective range. Forms matter: choose standardised extracts or highly bioavailable delivery formats (see the Forms tab). Take as directed.
Side effects and cautions
Generally well-tolerated. Avoid if you: Avoid during pregnancy and breastfeeding (thymol may be embryotoxic in high doses). Use caution with thyroid conditions (thyme may affect thyroid hormone levels). Essential oil is highly concentrated and should not be taken internally without professional guidance..
The evidence
Human clinical trials and mechanistic research support the use of Thyme Leaf for its primary indication. See the Research tab for full citations and study summaries.